Professional Documents
Culture Documents
Handout 4
Handout 4
who need short-term nutrition support (7–10 days) and do not requiremore than 2500
cal/day. PPN is contraindicated in patients who needafluidrestriction, such as in
Also referred to as total parenteral nutrition (TPN) or intravenoushyperalimentation, is patients with renal failure, liver failure, or congestiveheart failure.
the IV infusion of dextrose, water, fat, proteins, electrolytes, vitamins, and trace Central PN infuses a hypertonic, nutritionally complete solution throughalarge
elements. Because TPN solutionsarehypertonic (highly concentrated in diameter central vein so that it is quickly diluted. A physician threadsa
comparison to the soluteconcentration of blood), they are injected only into high- central venous catheter through the jugular or subclavian vein until thetipislocated just
flowcentral veins, where they are diluted by the client’s blood. above the heart.
Specially trained nurses can place a peripherally inserted central catheter (PICC) at
bedside.
The line is usually inserted on the inside of the elbow and threaded sothetipof the
catheter rests at the superior vena cava.
Composition of PN
PN solutions provide protein, carbohydrate, fat, electrolytes, vitamins, andtrace
elements in sterile water. Th
*Hypertonic solution causes water movement from the cell going to theareaof higher
solute concentration.
Catheter Placement Automated compounders can mix a 24-hour batch of PN solution into a
PN may be infused via peripheral or central veins. singlecontainer, that is, either a two-in-one formula (dextrose and amino acids) or
Peripheral parenteral nutrition (PPN) - is not widely used because solutionsinfused athree-in-one formula (dextrose, amino acids, and lipids). Most hospitals use a two-
into peripheral veins must beisotonic(i.e., they must havelowconcentrations of in-one systemand deliver lipids separately.
dextrose and amino acids) to prevent phlebitis andincreased risk of thrombus
formation.
reduce the risk of impaired liver function relatedtoexcessive glycogen and fat
deposition.
When it is given during the night, cyclic PN frees the patient to participateinnormal
activities during the day.
When the patient is able to begin consuming food enterally (orally or by tubefeeding),
the amount of PN is gradually reduced to compensate for calories consumedenterally.
It is recommended that PN be discontinued when enteral feedingprovides more than
60% of calorie goals (McClave et al., 2009).
Medications
Medications are sometimes added to intravenous solutions by the pharmacist or
infused
into them through a separate port. Patients receiving PN may have insulinordered if
glucose levels are greater than 150 to 200 mg/dL (levels higher thannormal are
considered acceptable because there is no fasting statewithcontinuous infusions).
Heparin may be added to reduce fibrin buildup on the catheter tip. In general,
medications should not be added to PN solutions because of the potential
incompatibilities of the medication and nutrients in the solution.